1 study found for:    19300261 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Bevacizumab Eliminates the Angiogenic Threat of Retinopathy of Prematurity
Condition: Retinopathy of Prematurity
Interventions: Drug: Bevacizumab;   Procedure: Conventional Laser for ROP

Indicates status has not been verified in more than two years